Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cholesterol affects retinal nerve fiber layer thickness in patients with multiple sclerosis with optic neuritis.
Employment status in multiple sclerosis: impact of disease-specific and non-disease-specific factors.
POEMS Syndrome in a Juvenile Initially Diagnosed as Treatment Resistant Chronic Inflammatory Demyelinating Polyneuropathy.
Exploration of Undertreatment and Patterns of Treatment of Depression in Multiple Sclerosis.
miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
Trunk kinematics during walking in persons with multiple sclerosis: The influence of body weight support.
Characterization of the NT2-derived neuronal and astrocytic cell lines as alternative in vitro models for primary human neurons and astrocytes.
Molecular analysis of polimorphisms in HLA-CLASS II DRB1* and IL7Rα possibly associated with multiple sclerosis susceptibility in a population sample of Rio de Janeiro.
Influence of female sex and fertile age on neuromyelitis optica spectrum disorders.
Optic neuritis as a phase 2 paradigm for neuroprotection therapies of multiple sclerosis: update on current trials and perspectives.
Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells.
Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosis.
Unusual deterioration in a patient with multiple sclerosis on natalizumab therapy.
Regulatory B Cells and Mechanisms.
Consistent reduction in the annualized rate of brain volume loss across phase 3 core and extension trials of fingolimod in relapsing multiple sclerosis.
Plaque-like demyelination in acute disseminated encephalomyelitis (ADEM) - an autopsy case report.
Cognition in Early Relapsing-Remitting Multiple Sclerosis: Consequences May Be Relative to Working Memory.
Limited TCF7L2 Expression in MS Lesions.
A polymorphism in the resistin gene promoter and the risk of multiple sclerosis.
Change in quality of life and predictors of change among patients with multiple sclerosis: a prospective cohort study.
[Guillain-Barré syndrome in infancy: The importance of electroneuromyography].
Undiagnosed neurological disease as a potential cause of male lower urinary tract symptoms.
Eye and hand motor interactions with the Symbol Digit Modalities Test in early multiple sclerosis.
The pathological and physiological roles of IL-6 amplifier activation.
Psychometric properties of quality of life and health-related quality of life assessments in people with multiple sclerosis.
Pages
« first
‹ previous
…
608
609
610
611
612
613
614
615
616
…
next ›
last »